메뉴 건너뛰기




Volumn 4, Issue 3, 2008, Pages 171-173

Commentary on "A roadmap for the prevention of dementia: The inaugural Leon Thal Symposium"

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; BETA SECRETASE INHIBITOR; CLOPIDOGREL; GAMMA SECRETASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; NOOTROPIC AGENT; ROFECOXIB; ROSIGLITAZONE;

EID: 43649085939     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2008.03.008     Document Type: Note
Times cited : (2)

References (11)
  • 1
    • 17844378691 scopus 로고    scopus 로고
    • Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction
    • P.H. Reddy G. Mani B.S. Park J. Jacques G. Murdoch W. Whetsell Jr Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction J Alzheimers Dis 7 2005 103 117
    • (2005) J Alzheimers Dis , vol.7 , pp. 103-117
    • Reddy, P.H.1    Mani, G.2    Park, B.S.3    Jacques, J.4    Murdoch, G.5    Whetsell, W.6
  • 3
    • 33947223454 scopus 로고    scopus 로고
    • Cerebrospinal fluid tau/β-Amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
    • A.M. Fagan C.M. Roe C. Xiong M.A. Mintun J.C. Morris D. Holtzman Cerebrospinal fluid tau/β-Amyloid42 ratio as a prediction of cognitive decline in nondemented older adults Arch Neurol 64 2007 343 349
    • (2007) Arch Neurol , vol.64 , pp. 343-349
    • Fagan, A.M.1    Roe, C.M.2    Xiong, C.3    Mintun, M.A.4    Morris, J.C.5    Holtzman, D.6
  • 4
    • 34447326955 scopus 로고    scopus 로고
    • Amyloid imaging in Alzheimer's disease
    • A. Nordberg Amyloid imaging in Alzheimer's disease Curr Opinion Neurol 20 2007 398 402
    • (2007) Curr Opinion Neurol , vol.20 , pp. 398-402
    • Nordberg, A.1
  • 5
    • 35648932901 scopus 로고    scopus 로고
    • Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease
    • K.E. Pike G. Savage V.L. Villemagne S. Ng S.A. Moss P. Maruff Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease Brain 130 2007 2837 2844
    • (2007) Brain , vol.130 , pp. 2837-2844
    • Pike, K.E.1    Savage, G.2    Villemagne, V.L.3    Ng, S.4    Moss, S.A.5    Maruff, P.6
  • 6
    • 15244360529 scopus 로고    scopus 로고
    • Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD
    • A.F. Fotenos A.Z. Snyder L.E. Girton J.C. Morris R.L. Buckner Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD Neurology 64 2005 1032 1039
    • (2005) Neurology , vol.64 , pp. 1032-1039
    • Fotenos, A.F.1    Snyder, A.Z.2    Girton, L.E.3    Morris, J.C.4    Buckner, R.L.5
  • 8
    • 33644832047 scopus 로고    scopus 로고
    • Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta(42) in humans
    • A.M. Fagan M.A. Mintun R.H. Mach S.Y. Lee C.S. Dence A.R. Shah Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta(42) in humans Ann Neurol 59 2006 512 519
    • (2006) Ann Neurol , vol.59 , pp. 512-519
    • Fagan, A.M.1    Mintun, M.A.2    Mach, R.H.3    Lee, S.Y.4    Dence, C.S.5    Shah, A.R.6
  • 10
    • 0037411512 scopus 로고    scopus 로고
    • Biological markers for therapeutic trials in Alzheimer's disease: proceedings of a biological markers working group—NIA initiative on neuroimaging in Alzheimer disease
    • R.A. Frank D. Galasko H. Hampel J. Hardy M.J. de Leon P.D. Mehta Biological markers for therapeutic trials in Alzheimer's disease: proceedings of a biological markers working group—NIA initiative on neuroimaging in Alzheimer disease Neurobiol Aging 24 2003 521 536
    • (2003) Neurobiol Aging , vol.24 , pp. 521-536
    • Frank, R.A.1    Galasko, D.2    Hampel, H.3    Hardy, J.4    de Leon, M.J.5    Mehta, P.D.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.